Sergio Paulo Magalhaes Simoes
AuthID: R-000-GG4
11
TITLE: Meeting the needs of breast cancer: A nucleolin's perspective
AUTHORS: Gregório, AC; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 125
AUTHORS: Gregório, AC; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 125
12
TITLE: Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
AUTHORS: Romano, S; Moura, V; Simoes, S; Moreira, JN; Goncalves, J;
PUBLISHED: 2018, SOURCE: SCIENTIFIC REPORTS, VOLUME: 8, ISSUE: 1
AUTHORS: Romano, S; Moura, V; Simoes, S; Moreira, JN; Goncalves, J;
PUBLISHED: 2018, SOURCE: SCIENTIFIC REPORTS, VOLUME: 8, ISSUE: 1
13
TITLE: Modulation of Angiogenic Activity by Light-Activatable miRNA-Loaded Nanocarriers
AUTHORS: Lino, MM; Simoes, S; Vilaca, A; Antunes, H; Zonari, A; Ferreira, L;
PUBLISHED: 2018, SOURCE: ACS NANO, VOLUME: 12, ISSUE: 6
AUTHORS: Lino, MM; Simoes, S; Vilaca, A; Antunes, H; Zonari, A; Ferreira, L;
PUBLISHED: 2018, SOURCE: ACS NANO, VOLUME: 12, ISSUE: 6
14
TITLE: Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films
AUTHORS: Borges, AF; Silva, C; Coelho, JFJ; Simoes, S;
PUBLISHED: 2017, SOURCE: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, VOLUME: 22, ISSUE: 2
AUTHORS: Borges, AF; Silva, C; Coelho, JFJ; Simoes, S;
PUBLISHED: 2017, SOURCE: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, VOLUME: 22, ISSUE: 2
15
TITLE: The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
AUTHORS: Fonseca, NA; Cruz, AF; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 113
AUTHORS: Fonseca, NA; Cruz, AF; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 113
16
TITLE: Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer
AUTHORS: Gregório, AC; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: Pathology and Oncology Research, VOLUME: 24, ISSUE: 4
AUTHORS: Gregório, AC; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: Pathology and Oncology Research, VOLUME: 24, ISSUE: 4
18
TITLE: Anaesthesia in dental medicine with local infiltrative anaesthetic technique Versus diploe anaesthesia delivery systems: Efficacy and behaviour, an experimental study [Anestesia em medicina dentária com técnica infiltrativa local Versus anestesia diploica: Eficácia e comportamento, um estudo experimental]
AUTHORS: Marques Ferreira, M; Carrilho, E; Paulo, S; Carrilho, T; Pedro Figueiredo, J; Macedo, R;
PUBLISHED: 2017, SOURCE: Acta Medica Portuguesa, VOLUME: 30, ISSUE: 12
AUTHORS: Marques Ferreira, M; Carrilho, E; Paulo, S; Carrilho, T; Pedro Figueiredo, J; Macedo, R;
PUBLISHED: 2017, SOURCE: Acta Medica Portuguesa, VOLUME: 30, ISSUE: 12
INDEXED IN: 
Scopus
Scopus19
TITLE: Targeting Cancer Stem Cells and Non-Stem Cancer Cells: The Potential of Lipid-Based Nanoparticles
AUTHORS: Cruz, AF; Fonseca, NA; Moura, V; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 23, ISSUE: 43
AUTHORS: Cruz, AF; Fonseca, NA; Moura, V; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 23, ISSUE: 43
20
TITLE: Synergistic cytotoxicity of targeted liposomes containing doxorubicin and C6-ceramide against nucleolin-overexpressing ovarian cancer cells is supported by the downregulation of the Akt pathway
AUTHORS: Cruz, AF; Fonseca, NA; Sampaio, SF; Moura, V; Almeida, RD ; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CANCER RESEARCH, VOLUME: 77, ISSUE: 13_Supplement
AUTHORS: Cruz, AF; Fonseca, NA; Sampaio, SF; Moura, V; Almeida, RD ; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CANCER RESEARCH, VOLUME: 77, ISSUE: 13_Supplement
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef